ESR1 and breast carcinoma: Considering that GPR30 was detected in CAFs in approximately 40% of the primary breast cancer tissues and was significantly associated with the expression of ERα+ in solid tumors [15], the GPR30 protein in CAFs might be the key to overcome the resistance to TAM in these patients.